Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation

FEBS Letters

Volumn 583, Issue 22, 2009, Pages 3649-3654

  Ando, Chieko ^a   Takahashi, Nobuyuki ^a   Hirai, Shizuka ^a   Nishimura, Kanako ^a   Lin, Shan ^a   Uemura, Taku ^a   Goto, Tsuyoshi ^a   Yu, Rina ^b   Nakagami, Joji ^c   Murakami, Shigeru ^c   Kawada, Teruo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b University of Ulsan   (South Korea)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Adipocyte; Inflammation; JNK; Luteolin; Macrophage

Indexed keywords

I KAPPA B; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INTERACTION; CHRONIC INFLAMMATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; CELL COMMUNICATION; CELL LINE; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; FOOD; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUTEOLIN; MACROPHAGES; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 71749121785     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.10.045     Document Type: Article

References (29)

1. Miranda P.J., DeFronzo R.A., Califf R.M., and Guyton J.R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149 (2005) 33-45
2. Fernández-Real J.M., and Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 24 (2003) 278-301
3. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
4. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trend Immunol. 25 (2004) 4-7
5. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
6. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 12 (2003) 1821-1830
7. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
8. Suganami T., Nishida J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2062-2068
9. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., Kotani H., Yamaoka S., Miyake K., Aoe S., Kamei Y., and Ogawa Y. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 84-91
10. Teillet F., Boumendjel A., Boutonnat J., and Ronot X. Flavonoids as RTK inhibitors and potential anticancer agents. Med. Res. Rev. 28 (2008) 715-745
11. Talhouk R.S., Karam C., Fostok S., El-Jouni W., and Barbour E.K. Anti-inflammatory bioactivities in plant extracts. J. Med. Food. 10 (2007) 1-10
12. Middleton E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
13. Takahashi N., Kawada T., Goto T., Kim C.S., Taimatsu A., Egawa K., Yamamoto T., Jisaka M., Nishimura K., Yokota K., Yu R., and Fushiki T. Abietic acid activates PPAR-gamma in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism. FEBS Lett. 550 (2003) 190-194
14. Hirai S., Kim Y.I., Goto T., Kang M.S., Yoshimura M., Obata A., Yu R., and Kawada T. Inhibitory effect of naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages. Life Sci. 81 (2007) 1272-1279
15. Kang M.S., Hirai S., Goto T., Kuroyanagi K., Ezaki Y., Takahashi N., and Kawada T. Dehydroabietic acid, herbal terpenoid, acts as ligands for PPARs in macrophages to regulate inflammation. Biochem. Biophys. Res. Commun. 369 (2008) 333-338
16. Takahashi N., Kawada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., Kawasaki H., Taira K., Yokoyama K.K., Kamei Y., and Fushiki T. Overexpression and ribozyme-mediated targeting of transcriptional coactivators, CREB binding protein (CBP) and p300, revealed their indispensable roles in adipocyte differentiation through the regulation of PPAR-gamma. J. Biol. Chem. 277 (2002) 16906-16912
17. Takahashi N., Kawada T., Goto T., Yamamoto T., Taimatsu A., Kimura K., Saitoh M., Hosokawa T., Miyashita K., and Fushiki T. Dual action of isoprenols to activate both PPAR-gamma and PPAR-alpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514 (2002) 315-322
18. Goto T., Takahashi N., Kato S., Egawa K., Ebisu S., Moriyama T., Fushiki T., and Kawada T. Phytol, a phytochemical compound, activates PPAR-alpha and regulates lipid metabolism in PPAR-alpha-expressing cells. Biochem. Biophys. Res. Commun. 337 (2005) 440-445
19. Kuroyanagi K., Kang M.S., Goto T., Kusudo T., Hirai S., Yu R., Yano M., Sasaki T., Takahashi N., and Kawada T. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 366 (2008) 219-225
20. Takahashi N., Kang M.S., Kuroyanagi K., Goto T., Kusudo T., Hirai S., Yu R., Yano M., Sasaki T., Murakami S., and Kawada T. Auraptene, a citrus fruit compound, regulates gene expression as a PPAR-alpha agonist in HepG2 hepatocytes. BioFactors 33 (2008) 25-32
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Hotamisligil G.S. The role of TNFα and TNF receptors in obesity and insulin resistance. J. Int. Med. 245 (1999) 621-625
23. Muoio D.M., and Newgard C.B. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 75 (2006) 367-401
24. de Ferranti S., and Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 54 (2008) 945-955
25. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., and Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J. Pharmacol. Exp. Ther. 296 (2001) 181-187
26. Lee J.Y., Sohn K.H., Rhee S.H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001) 16683-16689
27. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., and Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006) 3015-3025
28. Jang S., Kelley K.W., and Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA 105 (2008) 7534-7539
29. Kiokias S., and Gordon M.H. Dietary supplementation with a natural carotenoid mixture decreases oxidative stress. Eur. J. Clin. Nutr. 57 (2003) 1135-1140